1010 related articles for article (PubMed ID: 1292018)
1. Proliferation and neoplastic transformation of pigment cells in metallothionein/ret transgenic mice.
Takahashi M; Iwamoto T; Nakashima I
Pigment Cell Res; 1992 Nov; 5(5 Pt 2):344-7. PubMed ID: 1292018
[TBL] [Abstract][Full Text] [Related]
2. The ret oncogene can induce melanogenesis and melanocyte development in Wv/Wv mice.
Iwamoto T; Takahashi M; Ohbayashi M; Nakashima I
Exp Cell Res; 1992 Jun; 200(2):410-5. PubMed ID: 1374037
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of MMP-9 and TIMP-2 expression in malignant melanoma developed in metallothionein/RET transgenic mice.
Asai M; Kato M; Asai N; Iwashita T; Murakami H; Kawai K; Nakashima I; Takahashi M
Jpn J Cancer Res; 1999 Jan; 90(1):86-92. PubMed ID: 10076570
[TBL] [Abstract][Full Text] [Related]
4. Linkage between melanocytic tumor development and early burst of Ret protein expression for tolerance induction in metallothionein-I/ret transgenic mouse lines.
Kato M; Liu W; Akhand AA; Dai Y; Ohbayashi M; Tuzuki T; Suzuki H; Isobe K; Takahashi M; Nakashima I
Oncogene; 1999 Jan; 18(3):837-42. PubMed ID: 9989837
[TBL] [Abstract][Full Text] [Related]
5. Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene.
Iwamoto T; Taniguchi M; Wajjwalku W; Nakashima I; Takahashi M
Br J Cancer; 1993 Mar; 67(3):504-7. PubMed ID: 8439501
[TBL] [Abstract][Full Text] [Related]
6. Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene.
Iwamoto T; Takahashi M; Ito M; Hamatani K; Ohbayashi M; Wajjwalku W; Isobe K; Nakashima I
EMBO J; 1991 Nov; 10(11):3167-75. PubMed ID: 1915289
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a malignant melanocytic tumor cell line expressing the ret oncogene.
Taniguchi M; Iwamoto T; Nakashima I; Nakayama A; Ohbayashi M; Matsuyama M; Takahashi M
Oncogene; 1992 Aug; 7(8):1491-6. PubMed ID: 1630812
[TBL] [Abstract][Full Text] [Related]
8. Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene.
Portella G; Salvatore D; Botti G; Cerrato A; Zhang L; Mineo A; Chiappetta G; Santelli G; Pozzi L; Vecchio G; Fusco A; Santoro M
Oncogene; 1996 Nov; 13(9):2021-6. PubMed ID: 8934550
[TBL] [Abstract][Full Text] [Related]
9. c-Kit-targeting immunotherapy for hereditary melanoma in a mouse model.
Kato M; Takeda K; Kawamoto Y; Tsuzuki T; Hossain K; Tamakoshi A; Kunisada T; Kambayashi Y; Ogino K; Suzuki H; Takahashi M; Nakashima I
Cancer Res; 2004 Feb; 64(3):801-6. PubMed ID: 14871802
[TBL] [Abstract][Full Text] [Related]
10. RET tyrosine kinase enhances hair growth in association with promotion of melanogenesis.
Kato M; Takeda K; Kawamoto Y; Tsuzuki T; Dai Y; Nakayama S; Toriyama K; Tamada Y; Takahashi M; Nakashima I
Oncogene; 2001 Nov; 20(51):7536-41. PubMed ID: 11709725
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mouse model for skin malignant melanoma.
Kato M; Takahashi M; Akhand AA; Liu W; Dai Y; Shimizu S; Iwamoto T; Suzuki H; Nakashima I
Oncogene; 1998 Oct; 17(14):1885-8. PubMed ID: 9778055
[TBL] [Abstract][Full Text] [Related]
12. The ret oncogene products are membrane-bound glycoproteins phosphorylated on tyrosine residues in vivo.
Taniguchi M; Iwamoto T; Hamaguchi M; Matsuyama M; Takahashi M
Biochem Biophys Res Commun; 1991 Nov; 181(1):416-22. PubMed ID: 1958211
[TBL] [Abstract][Full Text] [Related]
13. A novel RFP-RET transgenic mouse model with abundant eumelanin in the cochlea.
Hayashi H; Sone M; Ito S; Wakamatsu K; Kato M; Nakashima I; Nakashima T
Hear Res; 2004 Sep; 195(1-2):35-40. PubMed ID: 15350277
[TBL] [Abstract][Full Text] [Related]
14. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.
Michiels FM; Chappuis S; Caillou B; Pasini A; Talbot M; Monier R; Lenoir GM; Feunteun J; Billaud M
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3330-5. PubMed ID: 9096393
[TBL] [Abstract][Full Text] [Related]
15. Growth factors and tyrosine protein kinases in normal and malignant melanocytes.
Halaban R
Cancer Metastasis Rev; 1991 Jun; 10(2):129-40. PubMed ID: 1873853
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
[TBL] [Abstract][Full Text] [Related]
17. Ultraviolet radiation induces both full activation of ret kinase and malignant melanocytic tumor promotion in RFP-RET-transgenic mice.
Kato M; Liu W; Akhand AA; Hossain K; Takeda K; Takahashi M; Nakashima I
J Invest Dermatol; 2000 Dec; 115(6):1157-8. PubMed ID: 11121157
[No Abstract] [Full Text] [Related]
18. Thyroid carcinomas in RET/PTC transgenic mice.
Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL
Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006
[TBL] [Abstract][Full Text] [Related]
19. Mapping of melanoma modifier loci in RET transgenic mice.
Dragani TA; Peissel B; Zanesi N; Aloisi A; Dai Y; Kato M; Suzuki H; Nakashima I
Jpn J Cancer Res; 2000 Nov; 91(11):1142-7. PubMed ID: 11092979
[TBL] [Abstract][Full Text] [Related]
20. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.
Santoro M; Chiappetta G; Cerrato A; Salvatore D; Zhang L; Manzo G; Picone A; Portella G; Santelli G; Vecchio G; Fusco A
Oncogene; 1996 Apr; 12(8):1821-6. PubMed ID: 8622903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
